Chengchun Chen
Department Of Infectious Diseases And Shenzhen Key Lab Of Endogenous Infection
Shenzhen, 518052, China
Shenzhen, 518052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
FabI-targeting pentacyclic triterpenoid celastrol resensitizes multidrug-resistant Gram-negative bacteria to polymyxins.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: February 08, 2026
Antibacterial and anti-virulence activity of the repurposed agent SX-682 against Staphylococcus aureus.
Journal: BMC microbiology
Published: January 06, 2026
Repurposing Azeliragon as a novel antibacterial agent against methicillin-resistant Staphylococcus aureus via combined membrane phospholipids and cell wall targeting.
Journal: Communications biology
Published: October 16, 2025
Derazantinib Inhibits the Planktonic Growth and Biofilm Formation of Staphylococcus aureus by Binding Membrane Phospholipids and Disrupting the Cell Membrane.
Journal: ACS infectious diseases
Published: May 14, 2025
Discovery of novel dihydropyrrolidone-thiadiazole compound crosstalk between the YycG/F two-component regulatory pathway and cell membrane homeostasis to combat methicillin-resistant Staphylococcus aureus.
Journal: European journal of medicinal chemistry
Published: June 04, 2024
Baohuoside I inhibits virulence of multidrug-resistant Staphylococcus aureus by targeting the transcription Staphylococcus accessory regulator factor SarZ.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 07, 2023
Antibacterial activities and action mode of anti-hyperlipidemic lomitapide against Staphylococcus aureus.
Journal: BMC microbiology
Published: February 15, 2022
Inhibition of Staphylococcus aureus and biofilm formation by the anthelminthic drug, triclabendazole.
Journal: The Journal of antibiotics
Published: November 22, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026